Combination of adenovirus-mediated TRAIL gene therapy and EGFR target therapy in NSCLC cellXU Fei, HUANG Yan, TIAN Ying, WANG Shu-sen, XIAO Jian, CAO Ya-bin, Saroj Niraula, LIN Tong-yu481-485
The growth inhibition effect of arsenic trioxide injection on A549 cell line and influence on survivin expressionHUANG Yong, SONG Yong, QIN Shu-kui486-489
Effects of norcantharidin on the growth and apoptosis of breast cancer cell line MCF-7adrLIANG Li, JIA Ting-zhen, ZHU Ying-bao, LI Ji-you490-493
Clinical analysis of 16 cases with primary ovarian lymphoma and review of literaturesGUO Cheng-cheng, HUANG Yan, ZHAI Lin-zhu, Saroj Niraula, YE Sheng, WANG Shu-sen, HUANG Hui-qiang, SUN Xiao-fei, XU Rui-hua, XIA Zhong-jun, GUAN Zhong-zhen, LIN Tong-yu494-497,500
The clinical study of HC regimen chemotherapy consisted of hydroxy camptothecin and carboplatin for the senile patients with advanced non- small cell lung cancerSHI Jian-hua, ZHU Zhi-zhen, HOU Shen, LIU Shuo-xin, HAN Zhen-qing, SUN Chuan-xun498-500
The expression and clinical significance of mammaglobin in breast cancer and axillary lymph nodesSHI Xi, CHEN Qiang, LIN Xiao-yan, HUANG Yi, ZHANG Zhi-feng501-504
Expression of PTEN and P53 protein in endometrial carcinoma and their clinical significanceYANG Chen, WU Yuan-zhe, LI Gui-mei505-508,511
Study of TCF regimen and PF regimen for advanced carcinoma of esophagusNI Xue-feng, WU Chang-ping, WANG He509-511
The studies of multi-tumor markers in the detection of aversion and prognosis in esophageal carcinomaSHAN Tan-you, FENG Xiao-shan, GAO She-gan, QU Zhi-feng, WANG Zhan-hui, ZHANG Luo, HAN Jing512-513,516
Clinical analysis for effect of late-course accelerated hyperfractionation and radiosensitizer (CMNa) for esophageal carcinomaGAO Fei, ZHAO Ying, YIN Xiao-xiang, YE Hong-xun, ZHOU Shao-bing, LIU Yang-chen514-516
